Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis. [Phase 3]
A Phase 3 trial comparing Secukinumab to Fumaderm in adults with moderate-to-severe psoriasis has completed and results were posted in 2017.
-
FDA approval · 2017-10-27FDA Approved: CLOBETASOL PROPIONATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for a generic clobetasol propionate topical product from Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis [Phase 3]
Phase 3 clinical trial update for guselkumab in moderate to severe plaque-type psoriasis completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial evaluating apremilast for active psoriatic arthritis using clinical assessments and a joint-periarticular-nail ultras…
-
FDA approval · 2017-10-13FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc., potentially expanding indications or updat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis [Phase 2]
This update reports results from a Phase 2 study evaluating the activity, safety, and tolerability of SRT2104 in adults with moderate to sev…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Completed clinical trial evaluating the comparative effectiveness of psoriasis treatments on systemic inflammation. The summary does not inc…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: The NOR-SWITCH Study [Phase 4]
Phase 4 clinical trial update for NOR-SWITCH study; completed with multiple inflammatory diseases assessed.
-
FDA approval · 2017-09-19FDA Approved: DESOXIMETASONE — Original Application (Viona Pharmaceuticals Inc)
FDA approved Desoximetasone from Viona Pharmaceuticals Inc via an Original Application (ANDA205206).
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease [Phase 4]
Phase 4 trial update evaluating the efficacy of combining fractional CO2 laser with topical tazarotene for nail psoriasis.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis
A completed clinical trial evaluating the Dermatologic Family Impact Scale in the parents of children with psoriasis to assess its reliabili…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test [Phase 1, Phase 2]
A Phase 1/2 trial evaluating topical C-82 for psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
This document notes the completion of a clinical trial evaluating the cost-effectiveness of systemic treatments for moderate-to-severe psori…
-
CLINICAL_TRIALS research · 2017-08-04Clinical Trial Update: An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis
This source describes an observational cohort study sponsored by King's College London to evaluate fatty liver disease and liver fibrosis in…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis [Phase 2]
Phase 2 dose-ranging study evaluating the safety and efficacy of the investigational compound GSK2586184 in patients with chronic plaque pso…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis [Phase 1]
This clinical trial update notes the completion of a Phase 1 safety study of BMS-986202 in healthy subjects and its evaluation for psoriasis…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: A Study in Participants With Moderate to Severe Psoriasis [Phase 2]
Phase 2 study in participants with moderate to severe psoriasis completed; results posted in 2017.
-
FDA approval · 2017-07-21FDA Approved: FLUOCINONIDE — Original Application (Novel Laboratories, Inc.)
FDA approval for fluocinonide from Novel Laboratories, Inc. as an Original Application (ANDA), representing first-time approval of this gene…
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis [Phase 2]
Phase 2b study of baricitinib in moderate to severe psoriasis completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis [Phase 1]
Betta Pharmaceuticals completed a Phase 1 trial evaluating icotinib hydrochloride cream for mild to moderate psoriasis.
-
CLINICAL_TRIALS withdrawal · 2017-07-17Clinical Trial Update: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study [Phase 2]
This clinical trial update reports that the Phase 2 study evaluating liraglutide for psoriatic arthritis (and related conditions) has been w…
-
FDA approval · 2017-07-17FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's generic fluocinonide acetonide as an original application (ANDA 202849) for topical tr…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients [Phase 1]
A Phase 1 clinical trial evaluating icotinib hydrochloride cream has completed in healthy adults and psoriasis patients to assess safety, to…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab [Phase 3]
Phase 3 trial evaluating cardiovascular risk markers in psoriasis patients treated with secukinumab; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Mechanism of Action Study for Psoriasis [Phase 4]
Phase 4 mechanism-of-action study in psoriasis completed; results have been posted by Tufts Medical Center.